Please refer to our Privacy policy for important information on the use of cookies. By continuing to use this website, you agree to this.

Press Release

Interserve wins contract to deliver high energy Proton Beam Therapy facility

by Interserve Press Office | Mar 31, 2014

Proton Beam Therapy facilityInterserve, the international support services and construction group, has been awarded a contract with The Christie NHS Foundation Trust to design, construct and co-ordinate a UK high energy Proton Beam Therapy facility. Subject to approval, construction work is planned to start on site in 2016, completing in 2018. The project is part of a ProCure 21+ framework, with Interserve appointed Principal Supply Chain Partner.

Proton beam therapy is a specialist form of radiotherapy which can very precisely target certain cancers, increasing success rates and reducing side-effects. Its introduction to the UK will bring the treatment closer to patients who currently have to travel abroad to receive it.

The team, consisting of HKS Architect, ARUP Engineers and Gleeds Cost Consultants, will draw on their experience and research to deliver Proton Beam Therapy in the UK. Over a two year period, Interserve travelled to various sites internationally to capture experience and lessons learnt from similar facilities, talking to clinicians and contractors, in order to enable a local team to deliver what the client required.

Championing BIMCurrently, Interserve and its partners are supporting and responding to specialist equipment vendors to provide concept designs. By designing the facility around the equipment, and being brought in so early in the equipment procurement stage, Interserve is helping The Christie to drive the project’s costs down and offer value for money. Full Level 2 BIM is being used throughout this design process. With the Department of Health requiring BIM Level 2 by 2016, Interserve is pioneering this approach ahead of the deadline.

The new Proton Beam Therapy facility builds on Interserve’s relationship with The Christie. Construction partners for over five years, The Christie and Interserve are committed to a further five years’ collaborative working to deliver best value projects with the finest clinical outcomes for patients.

Commenting on the project, Ian Renhard, MD of Interserve Construction said:

 “The team’s knowledge, experience, innovation and expertise, together with their dogged enthusiasm to learn so much about Proton Beam Therapy, demonstrated through its field research abroad, has contributed greatly to us winning this contract. We are delighted to continue our working relationship with The Christie, and look forward to delivering the project successfully."

- Ends -

For further information please contact:

Rhys Jones
Group PR Manager
Tel: 01189 60 2285
rhys.jones@interserveplc.co.uk

Karen Lewis
Edson Evers
01785 255146
karen@edsonevers.com

About Interserve

Interserve's vision is to redefine the future for people and places. We are one of the world's foremost support services and construction companies, operating in the public and private sectors in the UK and internationally. We offer advice, design, construction, equipment, facilities management and front-line public services. Interserve is based in the UK and is listed in the FTSE 250 index. We have gross revenue of £3.1 billion and a workforce of over 75,000 people worldwide.

www.interserve.com
For all news follow: @interservenews

About Proton Beam Therapy

Proton Beam Therapy (PBT) is a precise form of radiotherapy that uses charged particles instead of x-rays to deliver a dose of radiotherapy for patients. It can be a more effective form of treatment than conventional radiotherapy because it directs the radiotherapy more precisely with minimal damage to surrounding tissue. Evidence is growing that protons can be effective in treating a number of cancers, in particular children and young people with brain tumours, for whom PBT has shown to produce fewer side effects such as secondary cancers, growth deformity, hearing loss and learning difficulties.

About The Christie

  • The Christie opened in 1901 and is now one of Europe’s leading cancer centres and the largest single-site centre in Europe.
  • Because of its specialist nature, 26% patients are referred to The Christie from outside the Greater Manchester and Cheshire area.
  • It has one of the largest radiotherapy departments in the world as well as centres in Oldham and Salford. It also houses the UK’s largest brachytherapy service.
  • The Christie delivers chemotherapy treatment through the largest chemotherapy unit in the UK, as well as 10 other sites, its new mobile chemotherapy unit and at home. 

Share this


Latest Insight





Opportunities for all - Ex-service Personnel
Discover


SustainAbility
Our SustainAbilities journey

Watch our animation sharing the highlights from the fourth year of progress against Interserve’s SustainAbilities Plan.

Discover
Latest Insight





Opportunities for all - Ex-service Personnel
Discover
Reduced construction waste by 21% across our global operations #ingenuityatwork
Publication 2017 half-year report Download